Remove Drugs Remove Insulin Remove Licensing Remove Pharma Companies
article thumbnail

Arecor hopes London stock market float will raise profile of insulin products

pharmaphorum

UK biotech Arecor Therapeutics has announced plans to float on the London stock market, to fund plans to develop novel formulations of insulins and other biological drugs with enhanced properties. Arecor has four active licensing agreement in place with partners including Hikma and Inhibrx.

Insulin 52
article thumbnail

How the patient voice is becoming vital for drug approval

pharmaphorum

Rebecca Sanders from Lipodystrophy UK tells us how the patient voice helped convince NICE to approve a much-needed drug for this rare disease, and explores how regulators and pharma companies can help make patient involvement in HTA more impactful. This article appears in our free digital magazine Deep Dive: Market Access 2021.

Drugs 99
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Arecor heads for London Stock Exchange with drug reformulation strategy

pharmaphorum

Arecor Therapeutics is planning to float on the London stock market, to raise funding and awareness for its developmental portfolio of biologic drugs, which are based on already-marketed drugs reformulated to provide extra benefits for patients. .

Insulin 52
article thumbnail

A history of the pharmaceutical industry

pharmaphorum

Another military man in the drugs business was Edward Robinson Squibb, who as a naval doctor during the Mexican-American war of 1846–1848 threw the drugs he was supplied with overboard due to their low quality. This investment fuelled the development of drugs to come over the coming decades.

Medicine 145
article thumbnail

Pharma Marketing Network - Untitled Article

Pharma Marketing Network

Robin (Guest): And so we’re already seeing that and now with covid more and more companies are getting on board Medicare is already changing things they’re paying for In-clinic visits done by Telemedicine. Don ( PMN): Sure. Robin (Guest): Yup. Don ( PMN): Wow. Robin (Guest): So the exe yeah. Robin (Guest): Yup.

Insulin 52
article thumbnail

Pharma Marketing Network - Untitled Article

Pharma Marketing Network

Robin (Guest): And so we’re already seeing that and now with covid more and more companies are getting on board Medicare is already changing things they’re paying for In-clinic visits done by Telemedicine. Don ( PMN): Sure. Robin (Guest): Yup. Don ( PMN): Wow. Robin (Guest): So the exe yeah. Robin (Guest): Yup.

Insulin 52
article thumbnail

How Trump’s Canadian Drug Importation Executive Order Changes Things

Pharmacy Checkers

One of them is all about drug importation : measures already underway and new actions to help Americans buy more affordable prescription drugs from other countries. It has the potential to help many millions of Americans who are sick and tired of high drug prices or can’t even afford the medications prescribed to them.

Drugs 68